000 | 01968 a2200529 4500 | ||
---|---|---|---|
005 | 20250515020858.0 | ||
264 | 0 | _c20060711 | |
008 | 200607s 0 0 eng d | ||
022 | _a0003-9861 | ||
024 | 7 |
_a10.1016/j.abb.2006.02.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHenry, E C | |
245 | 0 | 0 |
_aA potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. _h[electronic resource] |
260 |
_bArchives of biochemistry and biophysics _cJun 2006 |
||
300 |
_a67-77 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aActive Transport, Cell Nucleus _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAtrophy _xchemically induced |
650 | 0 | 4 | _aBasic Helix-Loop-Helix Transcription Factors |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 | _aCell-Free System |
650 | 0 | 4 |
_aCytochrome P-450 CYP1A1 _xbiosynthesis |
650 | 0 | 4 |
_aDioxins _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFetus _xabnormalities |
650 | 0 | 4 |
_aGene Expression Regulation, Developmental _xdrug effects |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aPolychlorinated Biphenyls _xmetabolism |
650 | 0 | 4 |
_aPolychlorinated Dibenzodioxins _xadministration & dosage |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPropionates _xadministration & dosage |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
650 | 0 | 4 |
_aReceptors, Aryl Hydrocarbon _xagonists |
650 | 0 | 4 |
_aThymus Gland _xabnormalities |
650 | 0 | 4 |
_aXenobiotics _xmetabolism |
700 | 1 | _aBemis, J C | |
700 | 1 | _aHenry, O | |
700 | 1 | _aKende, A S | |
700 | 1 | _aGasiewicz, T A | |
773 | 0 |
_tArchives of biochemistry and biophysics _gvol. 450 _gno. 1 _gp. 67-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.abb.2006.02.008 _zAvailable from publisher's website |
999 |
_c16154023 _d16154023 |